Vaccines: Advancements, Impact, and the Road Ahead in Medicine

Ahmad Jamal

Authors

Ahmad Jamal Independent Researcher, Gulghust, 60700, Multan Pakistan

Keywords:

Emerging trends, medicine, vaccines, precision medicine, immunotherapy, gene editing, telemedicine, nanotechnology, global health initiatives, healthcare access, data privacy, interoperability, regulatory hurdles, workforce adaptation, ethical considerations, legal considerations

Abstract

The dynamic field of medicine is examined in this overview, with a focus on new developments, difficulties, and moral issues. It starts by breaking into the science behind vaccines, going over their types, development, and importance for public health. The effects of precision medicine, immunotherapy, gene editing, telemedicine, and nanotechnology on patient care, diagnosis, and treatment are examined. Immunotherapy uses the body's own defenses against diseases such as cancer, whereas precision medicine customizes therapies based on a patient's genetic profile. Telemedicine increases access to healthcare remotely, while gene editing may provide treatments for hereditary illnesses. Advanced imaging and targeted medicine delivery are made possible by nanotechnology. Global health programs strive to achieve equitable healthcare for all people by addressing healthcare gaps, particularly in low-income regions.. A number of legal and ethical issues surface, especially in relation to telemedicine and AI diagnostic technologies, raising concerns about consent and accountability. The field of medicine is poised for revolutionary progress in the future, provided that obstacles such as data protection, regulatory compliance, workforce adaptation, and ethical issues are skillfully managed. Healthcare systems that navigate successfully maximize medical innovation to deliver exceptional patient care everywhere.

References

Pedroni, M. J., Sondgeroth, K. S., Gallego-Lopez, G. M., Echaide, I. and Lau, A. O. (2013). Comparative transcriptome analysis of geographically distinct virulent and attenuated Babesia bovis strains reveals similar gene expression changes through attenuation. BMC Genomics 14, 763.

Detection of Bm86 antigen in different strains of Boophilus microplus and effectiveness of immunization with recombinant Bm86. Parasite Immunology 16, 493–500.

Perez-Llaneza, A., Caballero, M., Baravalle, E., Mesplet, M., Mosqueda, J., Suarez, C. E., Echaide, I., Katzer, F., Pacheco, G. M., Florin-Christensen, M. and Schnittger, L. (2010). Development of a tandem repeat-based multilocus typing system distinguishing Babesia bovis geographic isolates. Veterinary Parasitology 167, 196–204.

Pipano, E., Shkap, V., Kriegel, Y., Leibovitz, B., Savitsky, I. and Fish, L. (2002). Babesia bovis and B. bigemina: persistence of infection in Friesian cows following vaccination with live antibabesial vaccines. Veterinary Journal, 164, 64–68.

Posadas, J. B. and Lecuona, R. E. (2009). Selection of native isolates of Beauveria bassiana (Ascomycetes: Clavicipitaceae) for the microbial control of Rhipicephalus (Boophilus) microplus (Acari: Ixodidae). Journal of Medical Entomology 46, 284–291.

Pradel, G., Hayton, K., Aravind, L., Iyer, L. M., Abrahamsen, M. S., Bonawitz, A., Mejia, C. and Templeton, T. J. (2004). A multidomain adhesion protein family expressed in Plasmodium falciparum is essential for transmission to the mosquito. Journal of Experimental Medicine 199, 1533–1544.

Precigout, E., Delbecq, S., Vallet, A., Carcy, B., Camillieri, S., Hadj-Kaddour, K., Kleuskens, J., Schetters, T. and Gorenflot, A. (2004). Association between sequence polymorphism in an epitope of Babesia divergens Bd37 exoantigen and protection induced by passive transfer. International Journal for Parasitology 34, 585–593.

Rachinsky, A., Guerrero, F. D. and Scoles, G. A. (2007). Differential protein expression inovaries of uninfected and Babesia-infected southern cattle ticks, Rhipicephalus (Boophilus) microplus. Insect Biochemistry and Molecular Biology 37, 1291–1308.

Rachinsky, A., Guerrero, F. D. and Scoles, G. A. (2008). Proteomic profiling of Rhipicephalus (Boophilus) microplus midgut responses to infection with Babesia bovis. Veterinary Parasitology 152, 294–313.

Rajeshwari, K., Patel, K., Nambeesan, S., Mehta, M., Sehgal, A., Chakraborty, T. and Sharma, S. (2004). The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites. Infection and Immunity 72, 5515–5521.

Ramos, C. A., Araújo, F. R., Souza, I. I., Oliveira, R. H., Elisei, C., Soares, C. O., Sacco, A. M., Rosinha, G. M. and Alves, L. C. (2009). Molecular and antigenic characterisation of ribosomal phosphoprotein P0 from Babesia bovis. Memórias do Instituto Oswaldo Cruz 104, 998–1002.

Ramos, C. M., Cooper, S. M. and Holman, P. J. (2010). Molecular and serologic evidence for Babesia bovis-like parasites in white-tailed deer (Odocoileus virginianus) in south Texas. Veterinary Parasitology 172, 214–220.

Ribeiro, M. F., Bastos, C. V., Vasconcelos, M. M. and Passos, L. M. (2009). Babesia bigemina: in vitro multiplication of sporokinetes in Ixodes scapularis (IDE8) cells. Experimental Parasitology 122, 192–195.

Riek, J., Marcondes Klafke, G., Webster, A., Dall’Agnol, B., Scheffer, R., Araújo Souza, U., Bamberg Corassini, V., Vargas, R., Silveira dos Santos, J. and de Souza Martins, J. R. (2014). First report of fluazuron resistance in Rhipicephalus microplus: a field tick population resistant to six classes of acaricides. Veterinary Parasitology, in press, http:// dx.doi.org/10.1016/j.vetpar.2014.01.012.

Rodriguez, A. E., Couto, A., Echaide, I., Schnittger, L. and FlorinChristensen, M. (2010). Babesia bovis contains an abundant parasitespecific protein-free glycerophosphatidylinositol and the genes predicted to be involved in its assembly. Veterinary Parasitology 167, 227–235.

Rodriguez, A. E., Schnittger, L., Tomazic, M. L. and FlorinChristensen, M. (2013a). Current and prospective tools for the control of cattle-infecting Babesia parasites. In Protozoa: Biology, Classification and Role in Disease (ed. Castillo, V. and Harris, R.), pp. 1–44.

Nova Publishers, Hauppauge, NY, USA. Rodriguez, A. E., Zamorano, P., Wilkowsky, S., Torrá, F., Ferreri, L., Dominguez, M. and Florin-Christensen, M. (2013b). Delivery of recombinant vaccines against bovine herpesvirus type 1 gD and Babesia bovis MSA-2c to mice using liposomes derived from egg yolk lipids. Veterinary Journal 196, 550–551.

Rodriguez, A. E., Florin-Christensen, M., Flores, D. A., Echaide, I., Suarez, C. and Schnittger, L. (2014). The glycosylphosphatidylinositolanchored protein repertoire of Babesia bovis and its significance for erythrocyte invasion. Ticks and Tick-Borne Diseases 5, 343–348.

Rodríguez-Hernández, E., Mosqueda, J., Alvarez-Sánchez, M. E., Neri, A. F., Mendoza-Hernández, G. and Camacho-Nuez, M. (2012). The identification of a VDAC like protein involved in the interaction of Babesia bigemina sexual stages with Rhipicephalus microplus midgut cells. Veterinary Parasitology 187, 538–541. Rojas,

C., Figueroa, J. V., Alvarado, A., Mejia, P., Mosqueda, J. J., Falcon, A., Vega, C. A. and Alvarez, A. (2006). Bovine babesiosis live vaccine production: use of gamma irradiation on the substrate. Annals of the New York Academy of Sciences 1081, 405–416

Sabio y García, J. V., Farber, M., Carrica, M., Cravero, S., Macedo, G. C., Bigi, F., Oliveira, S. C., Rossetti, O. and Campos, E. (2008). Expression of Babesia bovis rhoptry associated protein 1 (RAP1) in Brucella abortus S19. Microbes and Infection 10, 635–641.

Salama, A. A., Terkawi, M. A., Kawai, S., Aboulaila, M., Nayel, M., Mousa, A., Zaghawa, A., Yokoyama, N. and Igarashi, I. (2013). Specific antibody to a conserved region of Babesia apical membrane antigen1 inhibited the invasion of B. bovis into the erythrocyte. Experimental Parasitology 135, 623–628.

Salas, J. H., González, M. M., Noa, M., Pérez, N. A., Díaz, G., Gutiérrez, R., Zazueta, H. and Osuna, I. (2003). Organophosphorus Monica Florin-Christensen and others 1590 pesticide residues in Mexican commercial pasteurized milk. Journal of Agricultural and Food Chemistry 51, 4468–4471.

Sánchez, C., Campos, E. and Oliva, A. G. (2009). Babesia bovis: effect of Albumax II and orotic acid in a low-serum in vitro culture. Experimental Parasitology 121, 274–278.

Santangelo, M. P., McIntosh, D., Bigi, F., Armôa, G. R., Campos, A. S., Ruybal, P., Dellagostin, O. A., McFadden, J., Mendum, T., Gicquel, B., Winter, N., Farber, M. and Cataldi, A. (2007). Mycobacterium bovis BCG as a delivery system for the RAP-1 antigen from Babesia bovis. Vaccine 25, 1104–1113.

Schneider, D. A., Yan, H., Bastos, R. G., Johnson, W. C., Gavin, P. R., Allen, A. J., Barrington, G. M., Herrmann-Hoesing, L. M., Knowles, D. P. and Goff, W. L. (2011). Dynamics of bovine spleen cell populations during the acute response to Babesia bovis infection: an immunohistological study. Parasite Immunology 33, 34–44.

Schnittger, L., Rodriguez, A. E., Florin-Christensen, M. and Morrison, D. A. (2012). Babesia: a world emerging. Infection, Genetics and Evolution 12, 1788–1809. Schuster, F. L. (2002). Cultivation of Babesia and Babesia-like blood parasites: agents of an emerging zoonotic disease. Clinical Microbiology Reviews 15, 365–373.

Shkap, V., Leibovitz, B., Krigel, Y., Hammerschlag, J., Marcovics, A., Fish, L., Molad, T., Savitsky, I. and Mazuz, M. (2005). Vaccination of older Bos taurus bulls against bovine babesiosis. Veterinary Parasitology 129, 235–242.

Shkap, V., de Vos, A. J., Zweygarth, E. and Jongejan, F. (2007a). Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity. Trends in Parasitology 23, 420–426.

Shkap, V., Rasulov, I., Abdurasulov, S., Fish, L., Leibovitz, B., Krigel, Y., Molad, T., Mazuz, M. L. and Savitsky, I. (2007b). Babesia bigemina: attenuation of an Uzbek isolate for immunization of cattle with live calf- or culture-derived parasites. Veterinary Parasitology 31, 221–226.

Shonhai, A. (2010). Plasmodial heat shock proteins: targets for chemotherapy. FEMS Immunology and Medical Microbiology 58, 61–74.

Silva, M. G., Ueti, M. W., Norimine, J., Florin-Christensen, M., Bastos, R. G., Goff, W. L., Brown, W. C., Oliva, A. and Suarez, C. E. (2010a). Babesia bovis expresses a neutralization-sensitive antigen that contains a microneme adhesive repeat (MAR) domain. Parasitology International 59, 294–297.

Silva, M. G., Ueti, M. W., Norimine, J., Florin-Christensen, M., Bastos, R. G., Goff, W. L., Brown, W. C., Oliva, A. and Suarez, C. E. (2010b). Babesia bovis expresses Bbo-6cys-E, a member of a novel gene family that is homologous to the 6-cys family of Plasmodium. Parasitology International 50, 13–18.

Silva, M. G., Domingos, A., Esteves, M. A., Cruz, M. E. and Suarez, C. E. (2013). Evaluation of the growth-inhibitory effect of trifluralin analogues on in vitro cultured Babesia bovis parasites. International Journal of Parasitology Drugs and Drug Resistance 3, 59–68.